Atlas Trials

Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)

Clinical trial NCT06917001 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06917001
Sponsor
Federal University of Minas Gerais
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Dengue Fever
Start date
2026-02-01
Primary completion
2027-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.